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The impact of urti
Upper respiratory tract infection (URTI) is a
nonspecific term used to describe acute infections
involving the nose, paranasal sinuses, pharynx and
larynx which serve as gateways to the trachea,
bronchi, and pulmonary alveolar spaces; of them
rhinitis and sinusitis usually coexist and are concur-
rent in most individuals; thus, the correct terminol-
ogy is now rhinosinusitis(1). Literature data reported
that 29% to 50% of all URTI develop into otitis
media (OM) (2,3,4).
The clinical syndrome of URTI comprises a
variety of symptoms. Cough is usually the main
symptom. Other symptoms are nasal
blockage/obstruction/congestion, discoloured nasal
discharge, fever and headache. Symptoms typically
peak after 2-3 days, and then gradually clear.
However, the cough may persist after the infection
has gone. This is because inflammation in the air-
ways, caused by the infection, can take a while to
settle. It may take 2-3 weeks, after other symptoms
have gone, for a cough to clear completely(5).
Factors contributing to urti
URTI are mainly infectious diseases resulting
from interplay between microbial load (viral and
bacterial) and immune response.
First of all, the host needs to recognize the
presence of microorganism through pattern recogni-
tion initiating the host defense mechanisms through
activation of multiple signal pathways. Host
defense mechanisms consist of both cellular
immune responses and release of soluble chemical
factors, which operate in the body through a com-
plex interaction with cytochines and other media-
tors(6). 
Literature data showed that in children submit-
ted to serial nasal lavages, in order to assess nasal
cytokine expression during acute upper respiratory
infections, interleukin 1, IL-8, IL-6, and tumor
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necrosis factor-a (TNF-α) were markedly elevated
in nasal lavage fluid during acute URTI compared
to baseline, and all except TNF-α decreased signifi-
cantly by 2-4 weeks later. Thus, cytokines are likely
to participate in regulation of respiratory virus-
induced inflammation(7).
Based on references and reports, the most
common causes of URTI are viruses. The most
common viruses isolated are rhinovirus, parain-
fluenza virus, coronavirus, adenovirus, respiratory
syncytial virus, coxsackievirus and influenza virus.
Fewer than 10% of cases is associated with
bacterial infection. The most common bacteria in
URTI are those belonging to the “infernal trio”
(Streptococcus pneumoniae, Haemophilus influen-
zae and Moraxella catarrhalis) and staphylococcus
aureus(8,9,10,11). 
URTI is the third most common reason for a
primary care provider consultation, with approxi-
mately a third of these attributed to acute rhinosi-
nusitis. Prevalence rate vary from 6-15% depending
on the methods used and population characteristics. 
Prevalence varies with season (higher in the
winter months) and climatic variations and increas-
ing with damp environment and air pollution.
Exposure to cigarette smoke increased susceptibili-
ty to rhinosinusitis.
Anatomical factors including Haller cells, con-
cha bullosa, septal deviation, choanal atresia, nasal
polyps and hypoplasia of sinuses have all been
associated with rhinosinusitis(6).
The role of allergy in rhinosinusitis is the sub-
ject of much debate. Literature data support the role
of allergy in predisposing for rhinosinusitis. In 1989
Savolainen reported that 25% of 224 patients with
sinusitis had allergy(12). In 1993, Ciprandi et al.
demonstrated that expression of the inflammatory
adhesion molecule, ICAM-1, which is a receptor
for rhinovirus, is elevated in allergic children(13); in
2006 they also conducted a cohort study that
showed that children with allergies have more fre-
quent and severe respiratory infections than chil-
dren without allergies(14). 
In contrast to the above literature, Pant et al in
2009 concluded that insufficient evidence exist to
confirm seasonal or perennial allergy as a signifi-
cant predisposing factor for rhinosinusitis. In con-
trast to this review, Lin recently reported that chil-
dren with atopy were more likely to develop rhinos-
inusits(16).
From urti to otitis media 
Infant and young children are prone to devel-
oping upper respiratory tract infections, especially
those who attend day care centers, which often
result in bacterial complications expecially acute
otitis media. 
Otitis media (OM) describes an inflammatory
process within the middle ear space that is general-
ly associated with accumulation of fluid and that
may lead to hearing loss, learning difficulties, and
delays in language development. The pathogenesis
of OM is multifactorial, involving the adaptive and
native immune system, Eustachian tube dysfunc-
tion, viral and bacterial load, and genetic and envi-
ronmental factors(16).
Two forms are recognized: acute otitis media
(AOM) and otitis media with effusion (OME).
AOM is defined as the presence of middle ear effu-
sion (MEE) in conjunction
with the rapid onset of one or more signs or
symptoms of inflammation in the middle ear, such
as otalgia, otorrhea, fever, or irritability. OME is
defined as MEE without signs or symptoms of an
acute infection; it may occur de novo or as a sequel
to AOM. Therefore, AOM and OME represent dif-
ferent stages of the OM continuum(17).
Otitis media is a common disease in children,
with an incidence range from 6% to 64%.The peak
age of incidence of AOM is at about 2 years of age,
probably leading to immaturity of function of the
immune system and to anatomic and functional
diversity of the eustachian tube (ie, nearly horizon-
tal orientation), and the other at about 5 years of
age, probably for because children attend the same
classes at school, with consequent increased sus-
ceptibility to infectious and allergic agents(18,19,20,21).
The pathogenesis of OME is clearly related to the
dysfunction of the Eustachian tube that is generally
related to upper respiratory tracts infections, ade-
noid hypertrophy, and craniofacial malformations,
such as cleft palate deformities and Down syn-
drome(22). 
As stated above literature data reported that
29% to 50% of all URTI develop into otitis
media(2,3,4). Recently, a study conducted by Martines
et al confirms data literature showing that children
who had previous URTI and ear infections were
significantly more likely to suffer from OME(23,24).
For otitis media to occur, bacteria colonized in
the nasopharynx mast enter the middle ear via
Eustachian tube. 
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Normally, bacteria are prevented from enter-
ing the middle ear by ciliated epithelium that lines
the Eustachian tube. Respiratory virus infection dis-
rupts the mucociliary system and impairs the ear’s
primary mechanical defense from bacterial inva-
sion. In addition, Eustachian tube dysfunction can
lead to reduced middle ear pressure, which forces
mucus, nasopharyngeal secretions, and bacteria into
the middle ear.
The disease is primarily caused by:
Streptococcus pneumaniae, Haemophils influenzae
and Moraxella catarralis(25). Viruses most commonly
detected during URI were different. Henderson et
al. used viral culture and reported that respiratory
syncytial virus, adenovirus, and influenza virus
were closely associated with AOM; the incidence of
AOM associated with rhinovirus URI was the low-
est. Ruuskanen et al. reported similar results. Vesa
et al. found that URI associated with respiratory
syncytial virus and rhinovirus had a higher rate of
AOM than did URI associated with adenovirus.
Pitkaranta et al. reported that rhinovirus (35%) was
the most common virus found in cases of nasopha-
ryngeal secretions and/or middle ear effusion in
children with AOM(6).
Management
A child with suspect URTI and OME has to be
assessed through clinical history, clinical examina-
tion, audiometry and timpanometry to confirm the
suspected diagnosis and proceed with the suitable
therapeutic strategy. Particularly the management of
these pathologic conditions should reach two
important objectives: first, to heal the inflammatory
process interesting the upper airways (restoring the
ventilation of the middle ears through Eustachian
tubes and reducing the bacterial load ); second, to
prevent new episodes of URTI and OME maintain-
ing the normal physiology of the upper airways
mucosa and reinforcing immunitary system.
So the presence of an URTI can be countered
with the administration of antibiotics (especially
macrolides), intranasal steroids (to reduce airway
eosinophil infiltration by preventing their increased
viability and activation) and/or anthistaminics (in
particular for allergic rhinitis) associated with nasal
saline solution irrigations (to help to rid the nose of
allergens and mucus). The latter treatment, used to
fight the acute inflammatory process, can also
reduce the probability to develop sinus infections
and allergic rhinitis.
Furthermore, the prevention of URTI can be
reached by the administration of oral bacterial
lysates, obtaining the reduction of number and
intensity of infective episodes. Specifically, OM-85
is a bacterial lysate of Streptococcus pneumoniae,
Haemophilus influenzae and other bacteria mainly
involved in URTI and in otitis media. It can prevent
recurrent infective flogosis of these districts and, as
shown by Heintz, it can be considered as an adjunct
to standard medical treatment in adults with chronic
rhinosinusitis without nasal polyps(26). 
Children with persistent OME documented
over a period of 3 months with a hearing level in
the better ear of 25–30 dB HL or worse averaged at
0.5, 1, 2 and 4 kHz  should be considered for surgi-
cal intervention (insertion of ventilation tubes).
Children who have undergone insertion of ventila-
tion tubes for OME should be followed up and their
hearing should be re-assessed.
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